NON-SMALL CELL LUNG CANCER ADENOCARCINOMA
Clinical trials for NON-SMALL CELL LUNG CANCER ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new NON-SMALL CELL LUNG CANCER ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for NON-SMALL CELL LUNG CANCER ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug infusion targets tough cancers in early trial
Disease control Recruiting nowThis study tests a new drug called ASP546C in people with advanced stomach, gastroesophageal junction, pancreatic, or certain other solid tumors. The drug is given as an infusion every 3 weeks. The study has two parts: Part 1 finds the best dose in stomach/GEJ cancer patients, an…
Matched conditions: NON-SMALL CELL LUNG CANCER ADENOCARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Astellas Pharma Global Development, Inc. • Aim: Disease control
Last updated Jul 03, 2026 19:21 UTC
-
New Two-Part cancer drug enters first human tests
Disease control Recruiting nowThis early-stage trial is testing a new drug called TGW101 in people with advanced solid tumors that have not responded to other treatments. TGW101 is given in two parts: an antibody-drug conjugate and a chemical trigger that activates it. The main goal is to check safety and fin…
Matched conditions: NON-SMALL CELL LUNG CANCER ADENOCARCINOMA
Phase: PHASE1 • Sponsor: Tagworks Pharmaceuticals BV • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC